Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Effects on the Developing Microbiome in Preterm Neonates
NCT02784821Phase 2Completed
- Sponsor
- University of Florida
- Start
- Jan 2017
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Infection (4 arms), sponsored by University of Florida. Primary endpoint: Number of Events of Composite Morbidities and Mortality, Including Necrotizing Enterocolitis (NEC), Late Onset Sepsis (LOS), Bronchopulmonary Dysplasia (BPD) and Death up to 1 year. Started Jan 2017; status: completed.
02
Conditions
Infection
Beyond the preview
Go deeper on NCT02784821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784821.